Advanced search×

The antiplatelet and antithrombotic actions of statins.

John V JV Mitsios, Athanasios I AI Papathanasiou, John A JA Goudevenos, and Alexandros D AD Tselepis

Audio, Transactions of the IRE Professi... 16(34):3808-14 (2010) PMID 21128896

Several studies over the last years have demonstrated that statins exhibit actions beyond that of lipid-lowering (pleiotropic effects) ranging from improving endothelial function, modulating the inflammatory response, maintaining plaque stability and preventing thrombus formation. Since the interplay among platelets, cells and other components of atherosclerotic lesions as well as the coagulation system play an important role in the progression of atherosclerosis and in the development of acute coronary syndromes, these non-lipid properties of statins may help to explain the early and significant reduction of cardiovascular events reported in several clinical trials of statin therapy. This review focuses on the experimental and clinical results regarding the antiplatelet/antithrombotic effects of statins.

Version: za2963e q8za2 q8zbf q8zc3 q8zd0 q8ze1 q8zf0 q8zge
Buy PDF

Similar articles you may find interesting…

  1. Bile Acid and Sterol Metabolism with Combined HMGCoA Reductase and PCSK9 Suppression.
    Rex A Parker, Ricardo A Garcia, and Siew P Ho

    J Lipid Res (2013) PMID 23614904

    PCSK9 inhibition markedly augments the LDL lowering action of statins. The combination is being evaluated for long-term effects on atherosclerotic disease outcomes. However, effects of combined treatment on hepatic cholesterol and bile acid metabolism have not yet been reported. To s...
    PDF not found
  2. Design and Synthesis of Dual-action Inhibitors Targeting Histone Deacetylases and HMG-CoA Reductase for Cancer Treatment.
    Jhih-Bin Chen, Ting-Rong Chern, and Jim-Min Fang

    J Med Chem (2013) PMID 23570542

    A series of dual-action compounds were designed to target histone deacetylase (HDAC) and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) by having a hydroxamate group essential for chelation with the zinc ion in the active site of HDAC and the key structural elements of statin...
    Buy PDF
  3. Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade.
    Hang-Lung Chang, Chih-Yu Chen, and Ming-Jen Hsu

    ACTA-BIOENERG (2013) PMID 23583370

    Simvastatin decreased cell viability and induced cell apoptosis in HCT116 cells. These results are associated with the modulation of p21(cip/Waf1) and survivin. Survivin knockdown using survivin siRNAs also decreased cell viability and induced cell apoptosis. Simvastatin's actions on p21(cip/Waf1),...
    Buy PDF